CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer.
Wang J, Zhang R, Lin Z, Zhang S, Chen Y, Tang J, Hong J, Zhou X, Zong Y, Xu Y, Meng R, Xu S, Liu L, Zhang T, Yang K, Dong X, Wu G.
Wang J, et al. Among authors: wu g.
J Hematol Oncol. 2020 Jul 20;13(1):99. doi: 10.1186/s13045-020-00926-x.
J Hematol Oncol. 2020.
PMID: 32690037
Free PMC article.